Imperial College London

DrAlessiaDavid

Faculty of Natural SciencesDepartment of Life Sciences

Lecturer in Bioinformatics and Data Intensive Biology
 
 
 
//

Contact

 

+44 (0)20 7594 5333alessia.david09

 
 
//

Location

 

Department of BioinformaticsSir Ernst Chain BuildingSouth Kensington Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Zhang:2020:10.1126/science.abd4570,
author = {Zhang, Q and Bastard, P and Liu, Z and Le, Pen J and Moncada-Velez, M and Chen, J and Ogishi, M and Sabli, IKD and Hodeib, S and Korol, C and Rosain, J and Bilguvar, K and Ye, J and Bolze, A and Bigio, B and Yang, R and Arias, AA and Zhou, Q and Zhang, Y and Onodi, F and Korniotis, S and Karpf, L and Philippot, Q and Chbihi, M and Bonnet-Madin, L and Dorgham, K and Smith, N and Schneider, WM and Razooky, BS and Hoffmann, H-H and Michailidis, E and Moens, L and Han, JE and Lorenzo, L and Bizien, L and Meade, P and Neehus, A-L and Ugurbil, AC and Corneau, A and Kerner, G and Zhang, P and Rapaport, F and Seeleuthner, Y and Manry, J and Masson, C and Schmitt, Y and Schlüter, A and Le, Voyer T and Khan, T and Li, J and Fellay, J and Roussel, L and Shahrooei, M and Alosaimi, MF and Mansouri, D and Al-Saud, H and Al-Mulla, F and Almourfi, F and Al-Muhsen, SZ and Alsohime, F and Al, Turki S and Hasanato, R and van, de Beek D and Biondi, A and Bettini, LR and D'Angio, M and Bonfanti, P and Imbe},
doi = {10.1126/science.abd4570},
journal = {Science},
pages = {1--16},
title = {Inborn errors of type I IFN immunity in patients with life-threatening COVID-19},
url = {http://dx.doi.org/10.1126/science.abd4570},
volume = {370},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Clinical outcome upon infection with SARS-CoV-2 ranges from silent infection to lethal COVID-19. We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern TLR3- and IRF7-dependent type I interferon (IFN) immunity to influenza virus, in 659 patients with life-threatening COVID-19 pneumonia, relative to 534 subjects with asymptomatic or benign infection. By testing these and other rare variants at these 13 loci, we experimentally define LOF variants in 23 patients (3.5%), aged 17 to 77 years, underlying autosomal recessive or dominant deficiencies. We show that human fibroblasts with mutations affecting this pathway are vulnerable to SARS-CoV-2. Inborn errors of TLR3- and IRF7-dependent type I IFN immunity can underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection.
AU - Zhang,Q
AU - Bastard,P
AU - Liu,Z
AU - Le,Pen J
AU - Moncada-Velez,M
AU - Chen,J
AU - Ogishi,M
AU - Sabli,IKD
AU - Hodeib,S
AU - Korol,C
AU - Rosain,J
AU - Bilguvar,K
AU - Ye,J
AU - Bolze,A
AU - Bigio,B
AU - Yang,R
AU - Arias,AA
AU - Zhou,Q
AU - Zhang,Y
AU - Onodi,F
AU - Korniotis,S
AU - Karpf,L
AU - Philippot,Q
AU - Chbihi,M
AU - Bonnet-Madin,L
AU - Dorgham,K
AU - Smith,N
AU - Schneider,WM
AU - Razooky,BS
AU - Hoffmann,H-H
AU - Michailidis,E
AU - Moens,L
AU - Han,JE
AU - Lorenzo,L
AU - Bizien,L
AU - Meade,P
AU - Neehus,A-L
AU - Ugurbil,AC
AU - Corneau,A
AU - Kerner,G
AU - Zhang,P
AU - Rapaport,F
AU - Seeleuthner,Y
AU - Manry,J
AU - Masson,C
AU - Schmitt,Y
AU - Schlüter,A
AU - Le,Voyer T
AU - Khan,T
AU - Li,J
AU - Fellay,J
AU - Roussel,L
AU - Shahrooei,M
AU - Alosaimi,MF
AU - Mansouri,D
AU - Al-Saud,H
AU - Al-Mulla,F
AU - Almourfi,F
AU - Al-Muhsen,SZ
AU - Alsohime,F
AU - Al,Turki S
AU - Hasanato,R
AU - van,de Beek D
AU - Biondi,A
AU - Bettini,LR
AU - D'Angio,M
AU - Bonfanti,P
AU - Imberti,L
AU - Sottini,A
AU - Paghera,S
AU - Quiros-Roldan,E
AU - Rossi,C
AU - Oler,AJ
AU - Tompkins,MF
AU - Alba,C
AU - Vandernoot,I
AU - Goffard,J-C
AU - Smits,G
AU - Migeotte,I
AU - Haerynck,F
AU - Soler-Palacin,P
AU - Martin-Nalda,A
AU - Colobran,R
AU - Morange,P-E
AU - Keles,S
AU - Çölkesen,F
AU - Ozcelik,T
AU - Yasar,KK
AU - Senoglu,S
AU - Karabela,N
AU - Gallego,CR
AU - Novelli,G
AU - Hraiech,S
AU - Tandjaoui-Lambiotte,Y
AU - Duval,X
AU - Laouénan,C
AU - COVID-STORM,Clinicians
AU - COVID,Clinicians
AU - Imagine,COVID Group
AU - French,COVID Cohort Study Group
AU - CoV-Contact,Cohort
AU - Amsterdam,UMC Covid-19
AU - Biobank
AU - COVID,Human Genetic Effort
AU - NIAID-USUHS
AU - TAGC,COVID Immunity Group
AU - Snow,AL
AU - Dalgard,CL
AU - Milner,J
AU - Vinh,DC
AU - Mogensen,TH
AU - Marr,N
AU - Spaan,AN
AU - Boisson,B
AU - Boisson-Dupuis,S
AU - Bustamante,J
AU - Puel,A
AU - Ciancanelli,M
AU - Meyts,I
AU - Maniatis,T
AU - Soumelis,V
AU - Amara,A
AU - Nussenzweig,M
AU - García-Sastre,A
AU - Krammer,F
AU - Pujol,A
AU - Duffy,D
AU - Lifton,R
AU - Zhang,S-Y
AU - Gorochov,G
AU - Béziat,V
AU - Jouanguy,E
AU - Sancho-Shimizu,V
AU - Rice,CM
AU - Abel,L
AU - Notarangelo,LD
AU - Cobat,A
AU - Su,HC
AU - Casanova,J-L
DO - 10.1126/science.abd4570
EP - 16
PY - 2020///
SN - 0036-8075
SP - 1
TI - Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
T2 - Science
UR - http://dx.doi.org/10.1126/science.abd4570
UR - https://www.ncbi.nlm.nih.gov/pubmed/32972995
UR - https://science.sciencemag.org/content/370/6515/eabd4570/tab-article-info
UR - http://hdl.handle.net/10044/1/83123
VL - 370
ER -